EBIMEV

Welcome to the Brand page for “EBIMEV”, which is offered here for Pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis;.

Its status is currently believed to be active. Its class is unavailable. “EBIMEV” is believed to be currently owned by “Atara Biotherapeutics, Inc.”